ANI Pharmaceuticals is building a leading Rare Disease company focused on Serving Patients, Improving Lives
ANI Pharmaceuticals Announces Offer to Acquire Egetis Therapeutics, Expanding the Scope and Scale of Its Rare Disease Business
2026-11-05
$70.35
-0.54 (-0.76%)
Pricing delayed by 20 minutes
Last updated
2026-11-17 13:32:00